-
Special Column
  • About Hengyang
    • Snapshot
    • Economy
    • History and Culture
    • Honors
    • Friendly Exchanges
    • City Cards
    • Maps of Hengyang
    • Pictureview
  • Tourism
    • Top Eight Attractions
    • Tourist Routes
    • Tourism Dynamic
    • Hengyang Special
    • Transportation
    • Travel Tips
  • Investment
    • Investment Environment
    • Investment Dynamic
    • Investment Projects
    • Investment Guide
    • Investment Policies
    • Taxation
    • Industrial Parks
    • Enterprise Focus
  • Life
    • Shopping
    • Health
    • Cuisine
    • Education
    • Employment
    • Church
    • Service Guide
  • Current News
    • Hot News
    • Special Report
    • Hot Report
  • E-Government
    • Officials
    • Departments
    • Laws and Regulations
    • Development Planning
    • Special Reports
  • Online Service
    • Naturalization
    • International Marriage
    • Entry & Exit
    • Residence Affairs
    • Mailbox of Government
    • FAQ
    • Online Investigation
    • Forms for Download
  • User experience
    • 信息构建
    • 可用性
    • 语言规范
  • Special Column
    • PictureNews
    • TopNews
    • Video and Audio
    • RSS
    • wea_f2
  • AllDocsList
Nanyue Biopharming Co. Ltd has completed the first overseas export of blood products
From:衡阳市政府门户网址 | Date Add in:2022-11-15 20:55:46 [A  A]

Recently, 22,020 vials of human immunoglobulin for intravenous injection (commonly known as “IVIG”) produced by Nanyue Biopharming Co., Ltd completed the inspection and quarantine of special goods through Hengyang Customs, and arrived in Sri Lanka by special plane in Chengdu. It was reported that this batch of IVIG belonged to the emergency humanitarian aid drugs which were exported by China for foreign aid, with a total value of more than 10 million yuan.


According to report, blood products were special biopharming with high export standards and strict procedures. In order to ensure the successful completion of this international rescue task, Nanyue Biopharming not only achieved strict quality control from production to batch release and other links, but actively docked with the Hengyang Customs. Under the premise of quality and quantity assurance, it efficiently carried out export inspection related work and completed the customs clearance and release of this batch of drugs.


In order to improve production capacity and competitiveness, Nanyue Biopharming has continuously increased its technical transformation efforts in recent years. From 2019 to 2022, it has invested 50 million yuan in the intelligent upgrading of workshops. At present, five major information systems have been fully implemented, and the corporate governance incorporating standardization, systemization, digitization, improvement and innovation has been preliminarily formed. This year it even increased a new production line of factor products, which can not only meet the production of human fibrinogen (clinical trial stage) in the future, but also expand the overall production capacity of the company's coagulation factor products and improve the quality and efficiency of the enterprise.


“This batch of blood products export should be said to be the first time that our enterprise and Hunan Province's blood products are exported to foreign countries, which is of landmark and milestone significance.” Xiao Hanzu, chairman and general manager of Nanyue Biopharming, said that in the next step, Nanyue Biopharming would strengthen the construction of overseas sales team, further expand and deepen the international market, and boost foreign trade to a new level.


Translator: Jing


Sponsored by Hengyang Municipal People's Government, Undertaken by Hengyang Normal University
Co-sponsored by Information Office of Hengyang Municipal People's Government Technical Support & Design:Hengyang Normal University
ICP NO:05002289